Patents by Inventor Kenneth E. Eakins

Kenneth E. Eakins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulations
    Patent number: 4556671
    Abstract: Heterocyclic compounds of formula (I) ##STR1## and their acid addition salts, when administered topically, exhibit anti-inflammatory activity and do not produce the side-effects associated with the administration of certain other anti-inflammatories. The compounds of formula (I) may be administered topically as the compound alone or in a suitable topical pharmaceutical formulation.
    Type: Grant
    Filed: May 22, 1981
    Date of Patent: December 3, 1985
    Assignee: Burroughs Wellcome Co.
    Inventors: Frederick C. Copp, Kenneth E. Eakins
  • Thromboxane inhibition with burimamide
    Patent number: 4228176
    Abstract: The disclosure describes a method for selectively inhibiting thromboxane biosynthesis with Burimamide, a compound previously known to be a histamine H.sub.2 -receptor blocker. The discovery is useful in the treatment of a number of cardiovascular and inflammatory diseases in which thromboxane biosynthesis is involved.
    Type: Grant
    Filed: April 9, 1979
    Date of Patent: October 14, 1980
    Assignee: Nelson Research & Development Company
    Inventors: Kenneth E. Eakins, Geoffrey Allan
  • Colchicine ophthalmic composition and method of use
    Patent number: 4190673
    Abstract: A therapeutic composition comprising a topically administrable ophthalmic pharmaceutical carrier and colchicine. The foregoing composition temporarily alleviates the symptoms of glaucoma when topically administered to the eye.
    Type: Grant
    Filed: May 10, 1978
    Date of Patent: February 26, 1980
    Assignee: Nelson Research & Development Company
    Inventors: Kenneth E. Eakins, Parimal Bhattacherjee
  • Ophthalmic composition and method of use
    Patent number: 4188394
    Abstract: A therapeutic composition comprising a topically administrable ophthalmic pharmaceutical carrier and vinblastine. The fore-going composition temporarily alleviates the symptoms of glaucoma when topically administered to the eye.
    Type: Grant
    Filed: May 8, 1978
    Date of Patent: February 12, 1980
    Assignee: Nelson Research & Development Company
    Inventors: Kenneth E. Eakins, Parimal Bhattacherjee
  • Thromboxane inhibition with Burimamide
    Patent number: 4172139
    Abstract: The disclosure describes a method for selectively inhibiting thromboxane biosynthesis with Burimamide, a compound previously known to be a histamine H.sub.2 -receptor blocker. The discovery is useful in the treatment of a number of cardiovascular and inflammatory diseases in which thromboxane biosynthesis is involved.
    Type: Grant
    Filed: May 8, 1978
    Date of Patent: October 23, 1979
    Assignee: Nelson Research & Development Company
    Inventors: Kenneth E. Eakins, Geoffrey Allan